SYnAbs' vision is to fill the gap in the marketplace for innovative antibodies against poor immunogenic compounds and complex antigens. Targeting lipids, peptides, neoepitopes, toxins, epigenetic modifications and polysaccharides, SYnAbs has developed a strong expertise in immunology to break immunotolerance in rat and guinea pig species to generate unique monoclonal antibodies of extreme specificity and higher affinity.
In SYnAbs they trust
Unique monoclonal antibody products
Custom monoclonal antibody services
Stay relaxed.
Enjoy an unique one-stop-shop solution with dedicated experienced project manager: from animal housing to custom manufacturing up to several grams!
Stop wasting time & money !
Maximizing the success rate and the quality of your generated mAbs in rats and guinea pigs.
Meet with multiple species and varied immunization expert!
The benefits of our technology?
- Extreme specificity
- Higher affinity
- Excellent results for small, difficult and poor immunogenic antigens
- Additional epitope recognition
- Access to the lymph nodes
- Rat Fc close to the human one
- Ideal for mice antigens
Our 2019 agenda
February 1st
Feb 4th - Feb 5th
Feb 21st - Feb 22nd
March 11th - March 13th
April 2nd - April 5th
May 9th
May 21st - May 23rd
June 18th - June 19th
Aug 3rd - Aug 8th
Sep 10th - Sep 11th
Sep 10th - Sep 12th
Oct 15th - Oct 17th
Nov 11th - Nov 16th
Nov 12th - Nov 16th
Dec 10th - Dec 11th
Antwerpen, Belgium, BACR
Toulouse, France, Buzz4Bio mAb production
Leuven, Belgium, Life-on-chip
Alpach, Austria, The Alpach Workwhop
Vienna, Austria, BioProcess International
Ghent, Belgium, Knowledge for Growth
Hannover, Germany, Labvolution/Biotechnica
Oxford, United Kingdom, Pivotal Scientific
Anaheim, USA, AACC
Leuven, Belgium, Cellular heterogeneity in CNS
Copenhagen, Denmark, Nordic Life Science Days
Bale, Switzerland, Antibody European Congress
Dusseldorf, Germany, MEDICA
Lisbon, Portugal, PEGS
Marseille, France, Biofit
